A rare deal hitting most hard criteria: $4K/mo revenue with an extraordinary 83% profit margin, valued at just 1.5x annual profit—well below typical software valuations. Nineteen months of operating history with verified financials on TrustMRR demonstrates real traction in a niche health vertical. The founder's domain expertise (ex-snus user) and explicit rejection of low-effort development suggest genuine product-market fit. Primary risks are narrow TAM (nicotine cessation apps face platform policy friction and modest scale) and single-founder knowledge concentration; buyer must validate retention curves and ASP sustainability.
Building a dual-platform quit-smoking app from scratch with habit-tracking backend, notification scheduling, and social/accountability features requires iOS and Android native work or cross-platform framework (Flutter/React Native); $8-16K in AI-assisted dev subscription and API costs over 10 weeks is achievable for a solo founder. However, the deal heavily favors BUY because you are acquiring verified $3,325/mo monthly profit (80% margin of safety), 19 months of production operational knowledge, app store presence, existing user base (size unknown but live), and founder domain expertise in a regulated vertical where distribution and credibility matter far more than code. The software itself is reproducible; the customer base, app store ranking, and founder credibility are not. Buyer is not primarily paying for code—buyer is paying for a profitable, verified revenue stream in a niche where customer acquisition barriers are real and documented retention is unknown but likely valuable. If retention is 40%+ MoM with organic acquisition, this is exceptional value at 1.5x profit.
Cash estimate includes the AI tools, APIs and infrastructure needed for a solo founder to recreate the software. Build time is informational and lightly weighted. The verdict is driven mainly by customers, users, verified earnings, retention, distribution, brand, data and operating history.
iOS + Android app that helps people to track & quit nicotine pouches. Unique design + quality code, not the usual AI slop. I'm ex-snus user so the app is really finetuned based on my actual experience
Opens the original listing on TrustMRR
Get new listings with asking prices, monthly profit, deal scores, and key risks.
The best reviewed deals, concise and evidence-first. Unsubscribe anytime.
Preliminary screening based on marketplace and public data. Verify all financial, legal, technical, customer, and operational claims independently before making an acquisition decision. This is not financial or legal advice.